Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.
暂无分享,去创建一个
C H Fox | M. Ostrowski | C. Fox | J. Justement | A. Fauci | D. Schwartzentruber | A S Fauci | M. Mannix | D J Schwartzentruber | J S Justement | S K Stanley | M A Ostrowski | K Gantt | S Hedayati | M Mannix | K Roche | S. Stanley | K. Gantt | K. Roche | S. Hedayati | A. Fauci | M. L. Mannix | Susan Hedayati | Kim Roche
[1] D. Gor,et al. Transient elevation of serum HIV antigen levels associated with intercurrent infection. , 1991, AIDS.
[2] P. Earl,et al. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity , 1988, Journal of virology.
[3] E. Werner,et al. WHO WILL GET AIDS? , 1986, The Lancet.
[4] A. Namazi,et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination , 1995 .
[5] Z. Bentwich,et al. Immune activation is a dominant factor in the pathogenesis of African AIDS. , 1995, Immunology today.
[6] A. Fauci,et al. The effect of cytokines and pharmacologic agents on chronic HIV infection. , 1992, AIDS research and human retroviruses.
[7] Ashley T. Haase,et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.
[8] N. Nagelkerke,et al. Transition dynamics of HIV disease in a cohort of African prostitutes: a Markov model approach. , 1990, AIDS.
[9] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[10] P. Fultz,et al. Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. , 1992, AIDS research and human retroviruses.
[11] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[12] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[13] M P Dempsey,et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.
[14] A. Fauci,et al. Serologic and immunologic studies in patients with AIDS in North America and Africa , 1987 .
[15] G. Pantaleo,et al. Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[16] T. Waldmann,et al. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.
[17] P. D. Smith,et al. Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG. , 1991, Journal of immunology.
[18] G. Tudor-Williams. Early diagnosis of vertically acquired HIV-1 infection. , 1991, AIDS.
[19] Anthony S. Fauci,et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.
[20] R. Cheynier,et al. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. , 1986, Science.
[21] T. Elbeik,et al. Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.
[22] A. Fauci,et al. Induction of expression of HIV in latently or chronically infected cells. , 1989, AIDS research and human retroviruses.
[23] K. Sell,et al. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. , 1986, Journal of immunology.
[24] D. Ho. HIV-1 viraemia and influenza , 1992, The Lancet.
[25] C. Fox,et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse , 1993, The Journal of experimental medicine.
[26] R. Virmani,et al. Systemic lymphadenopathic histology in human immunodeficiency virus-1-seropositive drug addicts without apparent acquired immunodeficiency syndrome. , 1994, Human pathology.
[27] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[28] M. Giacca,et al. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction , 1992, Journal of clinical microbiology.
[29] P. Fultz,et al. Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: correlation between in vitro and in vivo events , 1994, Journal of virology.